20. November 2009 03:16
Research and Markets (http://www.researchandmarkets.com/research/60b63b/the_pricing_and_re) has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering.
[More]
19. November 2009 07:06
Astellas Pharma Inc. and XenoPort, Inc. today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as XP13512, as a potential treatment for restless legs syndrome (RLS).
[More]
f0eca311-c44f-448f-a056-e133d00304ae|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Calcium, Gabapentin, Immunology, Migraine, Nervous System, Neuroscience, New Drug Application, Oncology, Restless Legs Syndrome, Sleep, Urology
17. November 2009 06:48
IntelGenx Corp. is pleased to announce the results of a clinical pilot study that suggests IntelGenx has successfully developed a product that is bioequivalent to a leading branded anti-migraine therapy. The product (INT008) has been developed using IntelGenx's proprietary immediate release film "VersaFilm" drug delivery technology. VersaFilm provides a patent-protected method of formulating in a convenient and discrete dosage form.
[More]
17. November 2009 04:13
Research and Markets (http://www.researchandmarkets.com/research/63cb3f/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Neurological Disease" to their offering.
[More]
3cce24a5-df8d-4ff4-91db-360afa454a74|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Autophagy, Calcium, Cell, Epilepsy, Fibroblast, Gene Therapy, Huntington's Disease, Immunotherapy, Insomnia, Macrophage, Migraine, Multiple Sclerosis, Myelin, Neurological Disease, Neurology, Parkinson's Disease, Pfizer, Potassium, Potassium Channel, Restless Legs Syndrome, Stem Cell, Stroke
16. November 2009 11:25
NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
[More]
16. November 2009 11:16
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot.
[More]
12. November 2009 07:43
MAP Pharmaceuticals, Inc. today announced that it has secured a committed equity financing facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity Ltd. MAP Pharmaceuticals is not obligated to utilize any of the $60 million facility, which has a term of 24 months.
[More]
11. November 2009 23:48
Endo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.
[More]
0f809b82-6017-4c76-9c0b-3a2b2591ae51|0|.0
Posted in: Medical Patent News
Tags: Anti-Inflammatory, Cancer, Endocrinology, Migraine, Neuralgia, Neurology, Oncology, Osteoarthritis, Prostate Cancer, Puberty, Urology, Voltaren
11. November 2009 04:35
Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and information concerning the global market for pain therapeutics, R&D pipelines and company involvement in this field.
[More]
7. November 2009 01:31
GlaxoSmithKline and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010. The original PDUFA date for this NDA review was November 9, 2009.
[More]
6. November 2009 01:01
NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.
[More]
5. November 2009 01:03
Raptor Pharmaceutical Corp., today announced that data from a clinical trial of NGX426, the Company's orally administered non-opioid, AMPA/kainate antagonist, will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November 20-21, 2009 in San Francisco.
[More]
4. November 2009 06:33
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008.
[More]
5453c92a-b5f8-46f7-9b54-d7f13d9a2c7d|0|.0
Posted in: Business / Finance
Tags: Acne, Alzheimer's Disease, Biopsy, Bladder Cancer, Bone, Brain, Cancer, Cell, Dermatitis, Dermatology, Diabetes, Hospital, Migraine, Nausea, Orthopedic, Pregnancy, Psoriasis, Renal Failure, Ulcer
3. November 2009 01:48
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
[More]
3. November 2009 01:00
New research shows that a rare brain disorder that causes early dementia is highly hereditary. The study is published in the November 3, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
[More]
219e52c5-9bdd-4f06-a46f-a977928e0d8e|0|.0
Posted in: Medical Condition News
Tags: Brain, Dementia, DNA, Dystonia, Education, Epilepsy, Huntington's Disease, Migraine, Nervous System, Neurology, Neuroscience
Subscribe